bupranolol has been researched along with propranolol in 27 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (22.22) | 18.7374 |
1990's | 6 (22.22) | 18.2507 |
2000's | 13 (48.15) | 29.6817 |
2010's | 1 (3.70) | 24.3611 |
2020's | 1 (3.70) | 2.80 |
Authors | Studies |
---|---|
Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H | 1 |
Iakovidis, D; Jackman, GP; Louis, SN; Louis, WJ; Nero, TL | 1 |
Baker, JG | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Champigny, O; Holloway, BR; Ricquier, D | 1 |
Ehle, B; Gille, E; Kaumann, AJ; Lemoine, H | 1 |
Gerstenbrand, F; Klingler, D; Poewe, W | 1 |
Bacher, S; Beck, A; Conca, W; Raberger, G | 1 |
Kaumann, AJ; Lemoine, H; Münch, U; Wächter, W | 1 |
Kaumann, AJ; Lemoine, H | 1 |
Horinouchi, T; Koike, K; Takayanagi, I | 1 |
Berlan, M; Carpéné, C; Galitzky, J; Lafontan, M; Portillo, M; Reverte, M | 1 |
Kaumann, AJ | 1 |
Atgié, C; Berlan, M; Carpéné, C; Fontana, E; Galitzky, J; Lafontan, M | 1 |
Brawley, L; MacDonald, A; Shaw, AM | 1 |
Horinouchi, T; Koike, K | 5 |
Horinouchi, T; Koike, K; Yamamoto, Y | 1 |
Doze, P; Elsinga, PH; Maas, B; Vaalburg, W; Van Waarde, A; Wegman, T | 1 |
Akimoto, Y; Horinouchi, T; Koike, K; Tanaka, Y | 1 |
Brahmadevara, N; MacDonald, A; Shaw, AM | 1 |
Horinouchi, T; Koike, K; Michikawa, H; Tanaka, Y; Yamashita, Y | 1 |
Acland, EL; Convertino, M; Diatchenko, L; Dokholyan, NV; Gauthier, J; Maixner, W; Martin, LJ; Mogil, JS; Piltonen, MH | 1 |
Jóźwik, M; Kleszczewski, T; Modzelewska, B; Sulkowski, S | 1 |
1 review(s) available for bupranolol and propranolol
Article | Year |
---|---|
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1988 |
26 other study(ies) available for bupranolol and propranolol
Article | Year |
---|---|
LK 204-545, a highly selective beta1-adrenoceptor antagonist at human beta-adrenoceptors.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; CHO Cells; Cricetinae; Cyclopropanes; Female; Humans; Imidazoles; In Vitro Techniques; Ligands; Phenoxypropanolamines; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Trachea; Urea | 1999 |
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Algorithms; Animals; Cell Line; CHO Cells; Cricetinae; Dioxoles; Humans; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3 | 2005 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Regulation of UCP gene expression in brown adipocytes differentiated in primary culture. Effects of a new beta-adrenoceptor agonist.
Topics: Adipose Tissue, Brown; Adrenergic beta-Agonists; Animals; Bupranolol; Carrier Proteins; Cell Differentiation; Cells, Cultured; Gene Expression; Ion Channels; Isoproterenol; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; Mitochondrial Proteins; Phenoxyacetates; Propranolol; Rats; RNA, Messenger; Uncoupling Protein 1 | 1992 |
The affinity of (-)-propranolol for beta 1- and beta 2-adrenoceptors of human heart. Differential antagonism of the positive inotropic effects and adenylate cyclase stimulation by (-)-noradrenaline and (-)-adrenaline.
Topics: Adenylyl Cyclases; Bupranolol; Catecholamines; Drug Synergism; Epinephrine; Humans; In Vitro Techniques; Membranes; Myocardial Contraction; Myocardium; Neurons; Norepinephrine; Phenoxybenzamine; Propranolol; Receptors, Adrenergic, beta; Stereoisomerism; Stimulation, Chemical | 1985 |
[Therapy of essential tremor with special reference to the use of beta-blockers].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Bupranolol; Double-Blind Method; Female; Humans; Male; Metoprolol; Middle Aged; Pindolol; Prognosis; Propranolol; Sotalol; Tremor | 1982 |
Plasma insulin levels and beta-adrenoceptor antagonists. Relevance of the steric configuration of beta-adrenoceptor antagonists to their effect on glucose tolerance.
Topics: Adrenergic beta-Antagonists; Animals; Blood Glucose; Bupranolol; Dogs; Glucagon; Glucose Tolerance Test; Insulin; Propranolol; Stereoisomerism; Structure-Activity Relationship | 1983 |
Evidence that (+)-bupranolol interacts directly with myocardial beta-adrenoceptors. Control of optical purity with differential thermal analysis.
Topics: Animals; Bupranolol; Calorimetry, Differential Scanning; Cats; Female; Humans; Isoproterenol; Myocardium; Optical Rotatory Dispersion; Propanolamines; Propranolol; Rats; Receptors, Adrenergic; Receptors, Adrenergic, beta; Temperature | 1980 |
A novel analysis of concentration-dependence of partial agonism Ring-demethylation of bupranolol results in a high affinity partial agonist (K 105) for myocardial and tracheal beta-adrenoceptors.
Topics: Animals; Bupranolol; Cats; Dealkylation; Female; Guinea Pigs; Heart Rate; In Vitro Techniques; Kinetics; Male; Myocardial Contraction; Myocardium; Propanolamines; Propranolol; Receptors, Adrenergic; Receptors, Adrenergic, beta; Trachea | 1982 |
Possible mechanisms of beta-adrenoceptor-mediated relaxation induced by noradrenaline in guinea pig taenia caecum.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Cecum; Cyclic AMP; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Muscle Proteins; Muscle Relaxation; Muscle, Smooth; Norepinephrine; Propranolol; Receptors, Adrenergic, beta | 1995 |
Coexistence of beta 1-, beta 2-, and beta 3-adrenoceptors in dog fat cells and their differential activation by catecholamines.
Topics: Adenylyl Cyclases; Adipose Tissue; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Catecholamines; Cell Membrane; Dogs; Dose-Response Relationship, Drug; Epinephrine; Ethanolamines; Isoproterenol; Norepinephrine; Procaterol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Tetrahydronaphthalenes | 1993 |
(-)-CGP 12177-induced increase of human atrial contraction through a putative third beta-adrenoceptor.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Bupranolol; Female; Heart Atria; Humans; In Vitro Techniques; Male; Middle Aged; Myocardial Contraction; Propanolamines; Propranolol; Receptors, Adrenergic; Stimulation, Chemical | 1996 |
Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells.
Topics: Adipose Tissue; Adipose Tissue, Brown; Adrenergic beta-Agonists; Adult; Animals; Binding, Competitive; Biogenic Amines; Bupranolol; CHO Cells; Cricetinae; Dioxoles; Dogs; Ethanolamines; Female; Gene Expression; Guinea Pigs; Humans; Imidazoles; Iodine Radioisotopes; Iodocyanopindolol; Isoproterenol; Lipolysis; Male; Mammals; Mesocricetus; Norepinephrine; Octopamine; Oxygen Consumption; Propanolamines; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3; Species Specificity | 1999 |
Beta 1-, beta 2- and atypical beta-adrenoceptor-mediated relaxation in rat isolated aorta.
Topics: Acetylcholine; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Aorta, Thoracic; Bupranolol; Dose-Response Relationship, Drug; Imidazoles; In Vitro Techniques; Isoproterenol; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Norepinephrine; Pindolol; Propanolamines; Propranolol; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Substrate Specificity; Vasodilator Agents | 2000 |
Partial agonist activity of carteolol on atypical beta-adrenoceptors in the guinea pig duodenum.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Carteolol; Dose-Response Relationship, Drug; Duodenum; Epinephrine; Ethanolamines; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Muscle Relaxation; Norepinephrine; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Vasodilator Agents | 2000 |
The beta3-adrenoceptor-mediated relaxation induced by epinephrine in guinea pig taenia caecum.
Topics: Animals; Bupranolol; Cecum; Cyclic AMP; Epinephrine; Guinea Pigs; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth; Phentolamine; Propranolol; Receptors, Adrenergic, beta | 2000 |
(+/-)-Pindolol acts as a partial agonist at atypical beta-adrenoceptors in the guinea pig duodenum.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-3 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Catecholamines; Duodenum; Ethanolamines; Guinea Pigs; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth; Pindolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta | 2001 |
Functional properties of atypical beta-adrenoceptors on the guinea pig duodenum.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Alprenolol; Animals; Bupranolol; Carteolol; Clenbuterol; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Duodenum; Epinephrine; Ethanolamines; Fenoterol; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Muscle Relaxation; Nadolol; Norepinephrine; Phenylephrine; Pindolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Stereoisomerism | 2001 |
Agonistic activity of SR59230A at atypical beta-adrenoceptors in guinea pig gastric fundus and duodenum.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Dose-Response Relationship, Drug; Duodenum; Gastric Fundus; Guinea Pigs; In Vitro Techniques; Male; Muscle Relaxation; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Stereoisomerism | 2001 |
Further evidence that (+/-)-carteolol-induced relaxation is mediated by beta2-adrenoceptors but not by beta3-adrenoceptors in the guinea pig taenia caecum.
Topics: Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-3 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Carteolol; Cecum; Guinea Pigs; In Vitro Techniques; Isoproterenol; Kinetics; Male; Muscle Relaxation; Muscle, Smooth; Propanolamines; Propranolol; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3; Stereoisomerism | 2000 |
Synthesis and evaluation of radiolabeled antagonists for imaging of beta-adrenoceptors in the brain with PET.
Topics: Adrenergic beta-Antagonists; Animals; Brain; Bupranolol; Carbazoles; Carbon Radioisotopes; Carvedilol; Fluorine Radioisotopes; Male; Models, Animal; Organ Specificity; Pindolol; Propanolamines; Propranolol; Radioligand Assay; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Tissue Distribution; Tomography, Emission-Computed | 2002 |
The beta2- and beta3-adrenoceptor-mediated relaxation induced by fenoterol in guinea pig taenia caecum.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Butoxamine; Cecum; Dose-Response Relationship, Drug; Fenoterol; Guinea Pigs; Male; Muscle Relaxation; Osmolar Concentration; Propranolol; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3 | 2002 |
ALpha1-adrenoceptor antagonist properties of CGP 12177A and other beta-adrenoceptor ligands: evidence against beta(3)- or atypical beta-adrenoceptors in rat aorta.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Antagonists; Alprenolol; Animals; Aorta, Thoracic; Binding Sites; Bupranolol; Cell Membrane; Cerebral Cortex; Dose-Response Relationship, Drug; Ethanolamines; Imidazoles; Male; Muscle, Smooth, Vascular; Phenylephrine; Pindolol; Prazosin; Propanolamines; Propranolol; Radioligand Assay; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta-3; Tritium; United Kingdom; Vasoconstriction | 2004 |
Pharmacological characterization of the beta-adrenoceptor that mediates the relaxant response to noradrenaline in guinea-pig tracheal smooth muscle.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Albuterol; Animals; Atenolol; Bupranolol; Butoxamine; Desipramine; Desoxycorticosterone; Dose-Response Relationship, Drug; Female; Guinea Pigs; Histamine; Imidazoles; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth; Norepinephrine; Phentolamine; Propanolamines; Propranolol; Receptors, Adrenergic, beta-1; Trachea | 2007 |
Differences in the Antinociceptive Effects and Binding Properties of Propranolol and Bupranolol Enantiomers.
Topics: Adrenergic beta-Antagonists; Analgesics; Animals; Bupranolol; Disease Models, Animal; Female; Male; Mice; Nociception; Pain Measurement; Propranolol; Receptors, Adrenergic, beta; Stereoisomerism | 2015 |
Myometrial Responses to Beta-Adrenoceptor Antagonists in Gynecological Malignancies.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Bupranolol; Endometrial Neoplasms; Ethanolamines; Female; Genital Neoplasms, Female; Humans; Myometrium; Ovarian Neoplasms; Propanolamines; Propranolol; Prospective Studies; Uterine Cervical Neoplasms; Uterine Contraction; Uterus | 2021 |